Clinical trial
Phase IV, 9 Weeks Comparison Between MICARDIS 80 mg and Amlodipine 10 mg on…
NCT00242814 · Boehringer Ingelheim, Industry · Completed
Key facts
| NCT number | NCT00242814 |
|---|---|
| Title | Phase IV, 9 Weeks Comparison Between MICARDIS 80 mg and Amlodipine 10 mg on Biological PPAR Gamma Activities |
| Official title | A Phase IV Study, Prospective, Randomised, Open Label, Blinded Endpoint, Parallel Group, 9 Weeks of Comparison Between Oral Administration of Telmisartan Tablet (80mg Once Daily) and Amlodipine Tablet (10 mg Once Daily) on Biological PPAR Gamma Activities in Non Controlled Hypertensive Male Patients… |
| Lead sponsor | Boehringer Ingelheim, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Hypertension, Metabolic Syndrome X |
| Intervention type | Drug, Procedure |
| Interventions | Micardis, Amlodipine, Abdominal biopsy |
| Enrollment | 100 |
| Start date | Nov 3, 2005 |
| Primary completion | Mar 29, 2007 |
| First posted | Oct 21, 2005 |
| Last update posted | Dec 8, 2023 |
| Countries | France |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: